Moxonidine is a new-generation centrally acting antihypertensive drug, which is approved for the treatment of mild to moderate essential hypertension. moxonidine has been shown to present blood pressure-independent beneficial effects on insulin resistance syndrome. Reference standards of Moxonidine API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => N-(4-Chloro-6-methoxy-2-methylpyrimidin-5-yl)-N-(1-nitroso-4,5-dihydro-1H-imidazol-2-yl)nitrous amide [catalogue_number] => PA 13 0561002 [category_ids] => ,71,78,80,82,162, [chemical_name] => [weight] => 299.68 [form] => C9H10ClN7O3 [cas] => NA [pslug] => n-4-chloro-6-methoxy-2-methylpyrimidin-5-yl-n-1-nitroso-4-5-dihydro-1h-imidazol-2-yl-nitrous-amide-pa130561002 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 13 0561002
CAS :
Molecular Formula : C9H10ClN7O3
Molecular Weight : 299.68
stdClass Object ( [pname] => N-Nitroso-Moxonidine (mononitroso) [catalogue_number] => PA 13 0561003 [category_ids] => ,84,162, [chemical_name] => [weight] => 272.69 [form] => C9H13ClN6O2 [cas] => NA [pslug] => n-nitroso-moxonidine-mononitroso-pa130561003 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 13 0561003
Molecular Formula : C9H13ClN6O2
Molecular Weight : 272.69
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
